Related Experiment Video
Updated: Jun 4, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
[Alkaloid compounds in Nelumbinis Folium and their hypolipidemic effect]
Jian Jiang1, Qian-Nan Xu1, Li Che2
1School of Pharmaceutical Sciences, Xiamen University Xiamen 361000, China.
Abstract:
Four alkaloid compounds including one new compound and three known ones were isolated and extracted from the 70% ethanol extract of Nelumbinis Folium by silica gel column chromatography, octadecylsilyl(ODS) column chromatography and preparative high-performance liquid chromatography. Their structures were identified by nuclear magnetic resonance spectroscopy, high-resolution mass spectrometry, circular dichroism and other methods. Compound 1 was identified as a new compound and named as lotustine B(1). Compounds 2-4 were identified as nuciferin(2), dehydronuciferine(3), N-methylasimilobine(4). The effects of four isolated alkaloid compounds on total cholesterol(TC) and total triglycerides(TG) levels were evaluated by constructing a human hepatoma(HepG2) cell model of hyperlipidemia. The hypolipidemic effects of compounds 1-4 were also evaluated using oil red O staining experi-ments. The results showed that compound 4 can reduce the lipid levels of HepG2 cells and has potential hypolipidemic effects.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antihypertensive Drugs: Action of β1 Blockers
Phase I Reactions: Reductive Reactions
Antihypertensive Drugs: Types of β-Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

